Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas S Duesbery

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|October 7, 2004
Involvement of domain II in toxicity of anthrax lethal factorXudong Liang, John J Young, Sherrie A Boone, et al.
Investigative Ophthalmology & Visual Science|September 5, 2013
Identification of VEGF-independent cytokines in proliferative diabetic retinopathy vitreousJennifer L Bromberg-White, Louis Glazer, Robert Downer, et al.
International Journal of Oncology|May 9, 2015
Combined inhibition of MEK and mTOR has a synergic effect on angiosarcoma tumorgraftsNicholas J Andersen, Elissa B Boguslawski, Cynthia Y Kuk, et al.
Current Pharmaceutical Design|October 14, 2003
Novel protein targeted therapy of metastatic melanomaArthur E Frankel, Han-Mo Koo, Stephen H Leppla, et al.
Cell Cycle (Georgetown, Tex.)|February 5, 2008
Potent inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin: implications for broad anti-tumor efficacyRandall W Alfano, Stephen H Leppla, Shihui Liu, et al.
Molecular Cancer Therapeutics|September 20, 2005
BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxinRalph J Abi-Habib, Jeffrey O Urieto, Shihui Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinaseHan-Mo Koo, Matt VanBrocklin, Mary Jane McWilliams, et al.
Developmental Biology|April 30, 2002
Characterization of MPF and MAPK activities during meiotic maturation of Xenopus tropicalis oocytesJean-Francois L Bodart, Davina V Gutierrez, Angel R Nebreda, et al.
The EMBO Journal|November 1, 2003
Xp38gamma/SAPK3 promotes meiotic G(2)/M transition in Xenopus oocytes and activates Cdc25CEusebio Perdiguero, Marie-Jeanne Pillaire, Jean-Francois Bodart, et al.
Plos One|March 3, 2011
MEK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 melanoma cellsChih-Shia Lee, Karl J Dykema, Danielle M Hawkins, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|October 7, 2004
Involvement of domain II in toxicity of anthrax lethal factorXudong Liang, John J Young, Sherrie A Boone, et al.
Investigative Ophthalmology & Visual Science|September 5, 2013
Identification of VEGF-independent cytokines in proliferative diabetic retinopathy vitreousJennifer L Bromberg-White, Louis Glazer, Robert Downer, et al.
International Journal of Oncology|May 9, 2015
Combined inhibition of MEK and mTOR has a synergic effect on angiosarcoma tumorgraftsNicholas J Andersen, Elissa B Boguslawski, Cynthia Y Kuk, et al.
Current Pharmaceutical Design|October 14, 2003
Novel protein targeted therapy of metastatic melanomaArthur E Frankel, Han-Mo Koo, Stephen H Leppla, et al.
Cell Cycle (Georgetown, Tex.)|February 5, 2008
Potent inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin: implications for broad anti-tumor efficacyRandall W Alfano, Stephen H Leppla, Shihui Liu, et al.
Molecular Cancer Therapeutics|September 20, 2005
BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxinRalph J Abi-Habib, Jeffrey O Urieto, Shihui Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinaseHan-Mo Koo, Matt VanBrocklin, Mary Jane McWilliams, et al.
Developmental Biology|April 30, 2002
Characterization of MPF and MAPK activities during meiotic maturation of Xenopus tropicalis oocytesJean-Francois L Bodart, Davina V Gutierrez, Angel R Nebreda, et al.
The EMBO Journal|November 1, 2003
Xp38gamma/SAPK3 promotes meiotic G(2)/M transition in Xenopus oocytes and activates Cdc25CEusebio Perdiguero, Marie-Jeanne Pillaire, Jean-Francois Bodart, et al.
Plos One|March 3, 2011
MEK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 melanoma cellsChih-Shia Lee, Karl J Dykema, Danielle M Hawkins, et al.
Pageof 4